PHARMACEUTICALLY ELEGANT
Live / Allowed — Notice of allowance issued (as of 03 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99208694
- Mark type
- Stylized text
- Filed
- 29 May 2025
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Carrie Webb Olson
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents in the form of oral soluble film, sublingual film, and transmucosal film that facilitate the delivery of prescription pharmaceutical drug preparations; films dissolvable in the mouth for the oral delivery of prescription pharmaceutical drug preparations; pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, central nervous system, and psychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy, seizure disorders, and psychiatric disorders; pharmaceutical preparations for the prevention and treatment of sexual dysfunction; pharmaceutical preparations, namely, anticonvulsants, antiseizure medications, psychotropics, benzodiazepines, and mood stabilizing medications; pharmaceutical preparations for the treatment or prevention of allergic reaction, anaphylaxis, and asthma; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, hypertension, and pulmonary arterial hypertension; pharmaceutical preparations for the treatment of benign prostatic hyperplasia; pharmaceutical preparations for the treatment of migraine, tension, and cluster headaches
- Class 042 — Scientific and technological services: Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development
Owner
- Aquestive Therapeutics, Inc., Warren, NJ, US
- Aquestive Therapeutics, Inc., Warren, NJ, US
Prosecution history
- 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Aug 2025 — NON-FINAL ACTION E-MAILED
- 19 Aug 2025 — NON-FINAL ACTION WRITTEN
- 14 Aug 2025 — ASSIGNED TO EXAMINER
- 14 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 May 2025 — APPLICATION FILING RECEIPT MAILED
- 29 May 2025 — NEW APPLICATION ENTERED